From: Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial
Characteristic
Completed Trial (n = 18)
Withdrew (n = 4)
Pills Taken: median, range
351 (323–375)
0, < 16, 36, 172
Compliance: median, range
98% (90–104)%
0%, < 5%, 10%, 48%